Insight into selective mechanism of class of I-BRD9 inhibitors toward BRD9 based on molecular dynamics simulations

Chemical Biology & Drug Design
Jing SuJianzhong Chen

Abstract

Recently, bromodomain-containing protein 9 (BRD9), 7 (BRD7), and 4 (BRD4) have been potential targets of anticancer drug design. Molecular dynamic simulations followed by molecular mechanics Poisson-Boltzmann surface area calculation were performed to study the selective mechanism of I-BRD9 inhibitor H1B and its derivatives N1D, TVU, and 5V2 toward BRD9 and BRD4. The rank of our calculated binding free energies agrees with that of the experimental data. The results show that binding free energy of H1B to BRD7 is slightly lower than that of H1B to BRD9, and all four inhibitors bind more tightly to BRD9 than to BRD4. Decomposition of binding free energies into individual residues implies that Ile164 and Asn211 in BRD7 and Ile53 and Asn100 in BRD9 play a significant role in the selectivity of H1B toward BRD7 and BRD9. Besides, several key residues Phe44, Ile53, Asn100, Thr104 in BRD9 and Pro82, Lys91, Asn140, Asp144 in BRD4 that are located in the ZA-loop and BC-loop provide significant contributions to binding selectivity of inhibitors to BRD9 and BRD4. This study is expected to provide important theoretical guidance for rational designs of highly selective inhibitors targeting BRD9 and BRD4.

References

Dec 1, 1977·Annals of Biomedical Engineering·T G ColemanR L Darby
May 25, 1992·Nucleic Acids Research·S R HaynesI B Dawid
Jan 1, 1996·Journal of Molecular Recognition : JMR·D S GoodsellA J Olson
Sep 1, 1996·Genes & Development·W WangG R Crabtree
Jul 15, 1999·Nature Structural Biology·F Winston, C D Allis
Aug 31, 1999·Nature·I WhitehouseT Owen-Hughes
Mar 16, 2000·The EMBO Journal·T Kouzarides
Dec 26, 2001·Proceedings of the National Academy of Sciences of the United States of America·W Wang, P A Kollman
Jul 18, 2002·Accounts of Chemical Research·Gautam R Desiraju
Oct 24, 2002·Journal of Computational Chemistry·Araz JakalianChristopher I Bayly
Dec 4, 2003·Journal of Computational Chemistry·Holger Gohlke, David A Case
Apr 30, 2004·Journal of Computational Chemistry·Junmei WangDavid A Case
Aug 19, 2007·Oncogene·S MujtabaM-M Zhou
Feb 20, 2010·Science·Shimin ZhaoKun-Liang Guan
Jan 29, 2011·Molecular Medicine·Na'ama A Shein, Esther Shohami
Sep 29, 2011·Journal of Computational Chemistry·Beisi XuGuohui Li
Aug 17, 2012·The New England Journal of Medicine·Mark A DawsonBrian J P Huntly
Feb 14, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Zhixiang ChengJialiang Wang
May 2, 2013·Current Genomics·Baohua LiuZhongjun Zhou
May 23, 2013·European Journal of Medicinal Chemistry·Guodong Hu, Jihua Wang
Nov 20, 2013·Proceedings of the National Academy of Sciences of the United States of America·Sarah PicaudPanagis Filippakopoulos
Nov 26, 2013·Angewandte Chemie·Xavier LucasStefan Günther
Jan 7, 2014·PloS One·Kevin G McLurePeter R Young
Apr 23, 2014·Nature Reviews. Drug Discovery·Panagis Filippakopoulos, Stefan Knapp
Jun 17, 2014·Trends in Genetics : TIG·Anja F Hohmann, Christopher R Vakoc
Aug 7, 2014·Epigenetics & Chromatin·Martin PhilpottSusanne Müller
Apr 10, 2015·Journal of Medicinal Chemistry·Natalie H TheodoulouPhilip G Humphreys
Apr 14, 2015·Angewandte Chemie·Peter G K ClarkDarren J Dixon
Jul 9, 2013·Journal of Chemical Theory and Computation·Daniel R Roe, Thomas E Cheatham
Dec 31, 2015·Journal of Chemical Theory and Computation·Guohui LiHonglei Wang
Jan 23, 2016·Chemical Science·Matteo AldeghiPhilip C Biggin
Feb 26, 2016·Journal of Medicinal Chemistry·Laetitia J MartinDarryl McConnell

❮ Previous
Next ❯

Citations

Jan 10, 2019·ChemMedChem·Michael A CleggPhilip G Humphreys
Nov 5, 2019·Frontiers in Oncology·Ryland HaleZoë Walters
Jan 1, 2021·OncoTargets and Therapy·Xiuzuo ZhuLiling Tang
Jun 10, 2021·Organic & Biomolecular Chemistry·Ellen E GuestJonathan D Hirst
Aug 25, 2020·ACS Medicinal Chemistry Letters·Aymeric DolboisAmedeo Caflisch
Aug 28, 2021·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Qianqian WangXiaojun Yao

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.